PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis
- 1 April 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (4), 1324-1332
- https://doi.org/10.1046/j.1523-1755.2001.0590041324.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The role of vasoactive compounds, growth factors and cytokines in the progression of renal diseaseKidney International, 2000
- Increased epidermal growth factor in experimental diabetes related kidney growth in ratsDiabetologia, 1997
- Transforming Growth Factor β in Diabetic NephropathyDiabetes/Metabolism Research and Reviews, 1996
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end productsKidney International, 1995
- Renal injury from angiotensin II-mediated hypertension.Hypertension, 1992
- Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1992
- Endothelin stimulates PDGF secretion in cultured human mesangial cellsKidney International, 1990
- Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens.Proceedings of the National Academy of Sciences, 1989
- The kinetics of antibody binding to membrane antigens in solution and at the cell surfaceBiochemical Journal, 1980